TSTero Soukka

Tero Soukka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tero Soukka has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Disintegration of Hexagonal NaYF4:Yb3+,Er3+ Upconverting Nanoparticles in Aqueous Media: The Role of Fluoride in Solubility Equilibrium

    by Satu Lahtinen, Annika Lyytikäinen, Henna Päkkilä, Emmy Hömppi, Niina Perälä, Mika Lastusaari, Tero Soukka


  • Array-in-well serodiagnostic assay utilizing upconverting phosphor label technology

    by Minna Ylihärsilä, Siina Alaranta, Susanne Lahdenperä, Satu Lahtinen, Benedict Arku, Klaus Hedman, Tero Soukka, Matti Waris


  • Upconverting nanoparticle to quantum dot FRET for homogeneous double-nano biosensors

    by Leena Mattsson, K. David Wegner, Niko Hildebrandt, Tero Soukka

    Both upconverting nanoparticles (UCNPs) and semiconductor quantum dots (QDs) have revolutionized optical biosensing because of their unique photophysical properties. However, their outstanding photostability, near-infrared (NIR) excitability, and colour tunability have never been combined for homogeneous mix-and-measure FRET (Förster resonance energy transfer) biosensors that do not require any washing or separation steps. Here we demonstrate that UCNP-to-QD FRET systems can be used for rapid homogeneous bioassays, which are essential tools for clinical diagnostics. One of the main drawbacks of UCNPs for FRET, namely their very low photoluminescence (PL) quantum yields, was efficiently overcome by using QD FRET acceptors with very strong spectral overlap with the UCNP donors. This resulted in unrivalled Förster distances for UCNP-based FRET pairs of up to 6 nm. We could quantify the prototypical analyte biotin (vitamin H) at low nanomolar concentrations and steady-state and time-resolved PL analysis showed that UCNP-to-QD FRET was caused by streptavidin-to-biotin binding. Immediate applicability in biosensing was demonstrated by biotin replacement assays over a large concentration range with IC50 values between 8 nM and 250 nM and detection limits down to 5 nM. The high photostability of the double-nanoparticle biosensor, the NIR excitation of UCNPs for minimal autofluorescence, and the spectral multiplexing capability of QDs offer a large potential for spectroscopy and imaging-based biosensing beyond in vitro diagnostics.


  • Aptamer-directed lanthanide chelate self-assembly for rapid thrombin detection

    by Henna Päkkilä, Sami Blom, Kari Kopra, Tero Soukka

    We report a sensitive assay method for homogeneous thrombin detection. The method is based on lanthanide chelate complementation, where the luminescent complex is split into two separate label moieties, which are intrinsically non-luminescent. A luminescent mixed chelate complex is formed only when the label moieties are brought into close proximity directed by two separate binding events of aptamers to the analyte. This results in high specificity in signal generation while time-resolved fluorescence detection eliminates the short lifetime autofluorescence, which is inherent to many homogeneous assays and limits their applicability. The developed method is also very rapid as the maximum signal is obtained in just five minutes. Lanthanide chelate complementation can be applied for the detection of other proteins when two binders recognizing separate epitopes of the analyte are available.


  • Rapid homogeneous PCR assay for the detection of Chlamydia trachomatis in urine samples

    by Ari Lehmusvuori, Etvi Juntunen, Antti-Heikki Tapio, Kaisu Rantakokko-Jalava, Tero Soukka, Timo Lövgren


  • Open Access

    Simultaneous detection of Human Immunodeficiency Virus 1 and Hepatitis B virus infections using a dual-label time-resolved fluorometric assay

    by Tiina Myyryläinen, Sheikh M Talha, Sathyamangalam Swaminathan, Raija Vainionpää, Tero Soukka, Navin Khanna, Kim Pettersson

    A highly specific and novel dual-label time-resolved immunofluorometric assay was developed exploiting the unique emission wavelengths of the intrinsically fluorescent terbium (Tb3+) and europium (Eu3+) tracers for the simultaneous detection of human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV) infections, respectively. HIV-1 infection was detected using a double antigen sandwich format wherein anti-HIV-1 antibodies were captured using an in vivo biotinylated version of a chimeric HIV-1 antigen and revealed using the same antigen labeled with Tb3+ chelate. Hepatitis B surface antigen (HBsAg), which served as the marker of HBV infection, was detected in a double antibody sandwich using two monoclonal antibodies (mAbs), one chemically biotinylated to capture, and the other labeled with Eu3+ nanoparticles, to reveal. The performance of the assay was evaluated using a collection (n = 60) of in-house and commercially available human sera panels. This evaluation showed the dual-label assay to possess high degrees of specificity and sensitivity, comparable to those of commercially available, single analyte-specific kits for the detection of HBsAg antigen and anti-HIV antibodies. This work demonstrates the feasibility of developing a potentially time- and resource-saving multiplex assay for screening serum samples for multiple infections in a blood bank setting.


  • Photon Upconversion in Homogeneous Fluorescence‐based Bioanalytical Assays

    by Tero Soukka, Terhi Rantanen, Katri Kuningas

    Upconverting phosphors (UCPs) are very attractive reporters for fluorescence resonance energy transfer (FRET)‐based bioanalytical assays. The large anti‐Stokes shift and capability to convert near‐infrared to visible light via sequential absorption of multiple photons enable complete elimination of autofluorescence, which commonly impairs the performance of fluorescence‐based assays. UCPs are ideal donors for FRET, because their very narrow‐banded emission allows measurement of the sensitized acceptor emission, in principle, without any crosstalk from the donor emission at a wavelength just tens of nanometers from the emission peak of the donor. In addition, acceptor dyes emitting at visible wavelengths are essentially not excited by near‐infrared, which further emphasizes the unique potential of upconversion FRET (UC‐FRET). These characteristics result in favorable assay performance using detection instrumentation based on epifluorometer configuration and laser diode excitation. Although UC‐FRET is a recently emerged technology, it has already been applied in both immunoassays and nucleic acid hybridization assays. The technology is also compatible with optically difficult biological samples, such as whole blood. Significant advances in assay performance are expected using upconverting lanthanide‐doped nanocrystals, which are currently under extensive research. UC‐FRET, similarly to other fluorescence techniques based on resonance energy transfer, is strongly distance dependent and may have limited applicability, for example in sandwich‐type assays for large biomolecules, such as viruses. In this article, we summarize the essentials of UC‐FRET, describe its current applications, and outline the expectations for its future potential.


  • Photochemical Characterization of Up-Converting Inorganic Lanthanide Phosphors as Potential Labels

    by Tero Soukka, Katri Kuningas, Terhi Rantanen, Ville Haaslahti, Timo Lövgren

    We have characterized commercially available up-converting inorganic lanthanide phosphors for their rare earth composition and photoluminescence properties under infrared laser diode excitation. These up-converting phosphors, in contrast to proprietary materials reported earlier, are readily available to be utilized as particulate reporters in various ligand binding assays after grinding to submicron particle size. The laser power density required at 980 nm to generate anti-Stokes photoluminescence from these particulate reporters is significantly lower than required for two-photon excitation. The narrow photoluminescence emission bands at 520–550 nm and at 650–670 nm are at shorter wavelengths and thus totally discriminated from autofluorescence and scattered excitation light even without temporal resolution. Transparent solution of colloidal bead-milled up-converting phosphor nanoparticles provides intense green emission visible to the human eye under illumination by an infrared laser pointer. In this article, we show that the unique photoluminescence properties of the up-converting phosphors and the inexpensive measurement configuration, which is adequate for their sensitive detection, render the up-conversion an attractive alternative to the ultraviolet-excited time-resolved fluorescence of down-converting lanthanide compounds widely employed in biomedical research and diagnostics.


  • Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology

    by Tero Soukka, Katri Antonen, Harri Härmä, Anne-Maria Pelkkikangas, Petri Huhtinen, Timo Lövgren


  • Open Access

    Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology

    by Tero Soukka, Janika Paukkunen, Harri Härmä, Stefan Lönnberg, Hanne Lindroos, Timo Lövgren

    Background: The extreme specific activity of the long-lifetime fluorescent europium(III) chelate nanoparticles and the enhanced monovalent binding affinity of multivalent nanoparticle-antibody bioconjugates are attractive for noncompetitive immunoassay. Methods: We used a noncompetitive, two-step immunoassay design to measure free prostate-specific antigen (PSA). Europium(III) chelate nanoparticles (107 nm in diameter) were coated with a monoclonal anti-PSA antibody (intrinsic affinity, 6 × 109 L/mol). The nanoparticle-antibody bioconjugates had an average of 214 active binding sites per particle and a monovalent binding affinity of 7 × 1010 L/mol. The assay was performed in a low-fluorescence microtitration well passively coated with an another monoclonal anti-PSA antibody (affinity, 2 × 1010 L/mol), and the europium(III) fluorescence was measured directly from the bottom of the well by a standard time-resolved microtitration plate fluorometer. Results: The detection limit (mean + 2 SD) was 0.040 ng/L (7.3 × 105 molecules/mL), and the dynamic detection range covered four orders of magnitude in a 3-h total assay time. The imprecision (CV) over the whole assay range was 2–10%. The detection limit of the assay was limited by the fractional nonspecific binding of the bioconjugate to the solid phase (0.05%), which was higher than the nonspecific binding of the original antibody (Conclusions: The sensitivity of the new assay is equal to that of the ambient-analyte, microspot immunoassay and will be improved by use of optimized, high binding-site density nanoparticle-antibody bioconjugates with reduced nonspecific binding and improved monovalent binding affinity.